Posterior Fossa Brain Tumor GroupNCT07810673
Physical Performance and Quality of Life in Children With Brain Tumors
An observational study of Posterior Fossa Brain Tumor Group and Healthy Control Group, run by Sarah Mohammed El-Abasiri at 1 site in Egypt.
Trial summary
This study is designed to assess physical performance and quality of life in children with posterior fossa brain tumors compared to healthy children. The trial evaluates parameters such as physical endurance, balance, muscle strength, gait characteristics, and quality of life measures to understand the functional… Read more about this study
- Who is it for?
- Ages 7 to 10 yearsHealthy volunteers can take part
- Conditions the study is for
- Posterior Fossa Brain Tumor Group, Healthy Control Group
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Dec 2025to 25 Dec 2026
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 7 to 10 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: Pediatric patients diagnosed with posterior fossa brain tumors recruited from treatment centers, alongside an age-matched group of healthy children serving as controls.
Who may be able to join
- - Children aged 7 to 10 years.
- Confirmed diagnosis of posterior fossa brain tumors.
- Medically stable and able to perform physical evaluations.
- Age-matched healthy children aged 7 to 10 years.
- No history of neurological, musculoskeletal, or oncological disorders.
Who cannot join
- Associated severe cognitive or visual impairments preventing test comprehension.
- Other concurrent major medical or orthopedic conditions affecting physical performance.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Maadi Military Hospital
Cairo
Sara M Elabasiry Mohamed, MSc, +20 10 91906219, d.ahmed.saber1987@gmail.com
About this study
Official title: ASSESSMENT OF PHYSICAL PERFORMANCE AND QUALITY OF LIFE IN CHILDREN WITH BRAIN TUMORS.
This study is designed to assess physical performance and quality of life in children with posterior fossa brain tumors compared to healthy children. The trial evaluates parameters such as physical endurance, balance, muscle strength, gait characteristics, and quality of life measures to understand the functional impact of the condition.
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Posterior Fossa Brain Tumor Group | Children aged 7 to 10 years diagnosed with posterior fossa brain tumors. | |
| Healthy Control Group | Age-matched healthy children acting as a control group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
6-Minute Walk Test (6MWT)
Measures walking distance in meters to evaluate physical endurance and functional capacity.
Measured: At baseline during the initial assessment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Sep 2026
- Study start1 Dec 2025
- Primary completion1 Dec 2026 (estimated)
- Study completion25 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Posterior Fossa Brain Tumor GroupStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sarah Mohammed El-Abasiri
- Sponsor type
- University, hospital or other
- Collaborators
- Maadi Military Hospital
- Responsible party
- Sponsor-investigator, Sarah Mohammed El-Abasiri, Cairo University
- Investigators
- Eman Ibrahim Elhadidy, Principal investigator, Cairo University Faculty of Physical Therapy
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07810673
- Sponsor's protocol ID
- P.T.REC/012/006217
- Status last verified
- Sep 2026
- First submitted
- 3 Sep 2026
- Last updated
- 9 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No